-
BG Medicine Inc. (NASDAQ:BGMD), Waltham, Mass. Mayo Clinic, Rochester, Minn. Business: Diagnostic BG Medicine said Mayo's Mayo Medical Laboratory began offering galectin-3 testing services based on BG Medicine's BGM …
Published on 5/21/2012
-
Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Business: Autoimmune, Drug delivery Biogen Idec launched Avonex Pen intramuscular autoinjector and Avostartgrip in the U.S. The single-use Avonex Pen, which is approved in …
Published on 5/21/2012
-
Debiopharm Group, Lausanne, Switzerland Galenica Ltd. (SIX:GALN), Bern, Switzerland Business: Cancer, Genitourinary Debiopharm granted Galenica's Vifor Pharma Ltd. specialty pharma business rights to commercialize a …
Published on 5/21/2012
-
Furiex Pharmaceuticals Inc. (NASDAQ:FURX), Morrisville, N.C. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Menarini Group, Florence, Italy Business: Genitourinary Johnson & Johnson's Alza Corp. and Janssen …
Published on 5/21/2012
-
MDxHealth S.A. (Euronext:MDXH),Liege, Belgium Predictive Biosciences Inc., Lexington, Mass. Business: Diagnostic MDxHealth said in its 1Q12 earnings that partner Predictive launched its CertNDx Bladder Cancer Assay. The…
Published on 5/21/2012
-
MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Business: Diagnostic MDxHealth launched its ConfirmMDx for Prostate Cancer in the U.S. The epigenetic laboratory-developed test (LDT) assesses the presence or absence of …
Published on 5/21/2012
-
Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Business: Cardiovascular Mylan launched generic cholesterol therapy atorvastatin in France, Belgium, the U.K., the Netherlands and Ireland. Pfizer Inc. (NYSE:PFE, New York, N.Y…
Published on 5/21/2012
-
Pathogenica Inc., Boston, Mass. Business: Diagnostic Pathogenica launched the Pathogenica Hospital Acquired Infection (HAI) BioDetection Kit to detect and monitor HAI infection for research use. The DNA sequencing …
Published on 5/21/2012
-
Phalanx Biotech Group, Hsinchu, Taiwan Business: Diagnostic Phalanx launched CytoOneArray worldwide for prenatal and postnatal detection of microdeletions and microduplications related to a spectrum of congenital …
Published on 5/21/2012
-
Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Diagnostic Rosetta launched its miRview kidney in the U.S. The molecular diagnostic is used to classify four kidney tumors: benign oncocytoma and clear cell…
Published on 5/21/2012
-
Teijin Pharma Ltd., Tokyo, Japan Business: Musculoskeletal Teijin said it launched Bonalon Bag for IV Infusion in Japan to treat osteoporosis. An oral formulation is available as Bonalon. In its FY11 earnings for the …
Published on 5/21/2012
-
Ariosa Diagnostics Inc., San Jose, Calif. Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. Business: Diagnostic LabCorp launched Ariosa's Harmony Prenatal Test in the U.S. and Canada to detect fetal …
Published on 5/14/2012
-
AssureRx Health Inc., Mason, Ohio Business: Pharmacogenetics AssureRx launched GeneSightRx ADHD worldwide as an aid to predict response to certain ADHD medications using cheek swab samples. The test analyzes variations …
Published on 5/14/2012
-
Bayer AG (Xetra:BAYN), Leverkusen, Germany Santen Pharmaceutical Co. Ltd. (Tokyo:4536; Osaka:4536), Osaka, Japan Business: Ophthalmic Bayer's Bayer Yakuhin Ltd. Japanese subsidiary partnered with Santen to co-promote …
Published on 5/14/2012
-
Bial-Portela & Ca. S.A., S. Mamede do Coronado, Portugal MediGene AG (Xetra:MDG), Martinsried, Germany Business: Infectious MediGene granted Bial-Portela's Bial-Industrial Farmaceutica S.A. subsidiary exclusive …
Published on 5/14/2012
-
BioSyent Inc. (TSX-V:RX), Toronto, Ontario Pharmazeutische Fabrik Montavit Ges.m.b.H., Absam, Austria Business: Neurology, Genitourinary BioSyent's BioSyent Pharma Inc. subsidiary launched sterile topical anesthetic …
Published on 5/14/2012
-
BL&H Co. Ltd., Seoul, South Korea Clinigen Group Ltd., Burton-on-Trent, U.K. Hospira Inc. (NYSE:HSP), Lake Forest, Ill. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Infectious Clinigen's Clinigen …
Published on 5/14/2012
-
Desitin Arzneimittel GmbH, Hamburg, Germany Pozen Inc. (NASDAQ:POZN), Chapel Hill, N.C. Business: Neurology Desitin received exclusive rights to develop and commercialize Pozen's migraine drug MT 400 in the EU, …
Published on 5/14/2012
-
DNAFORM, Yokohama City, Japan Source BioScience plc (LSE:SBS), Nottingham, U.K. Business: Bioinformatics, Supply/Service Source and DNAFORM launched a Japanese version of Source's GenomeCube database and web store that …
Published on 5/14/2012
-
Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Business: Endocrine/Metabolic Mitsubishi's P.T. Tanabe Indonesia subsidiary launched Livalo pitavastatin in Indonesia to treat hypercholesterolemia. …
Published on 5/14/2012
-
Pathway Genomics Corp., San Diego, Calif. Business: Supply/Service Pathway Genomics added a health coaching service to its Pathway Fit genetic testing service for food metabolism and exercise. The Pathway Fit Plus …
Published on 5/14/2012
-
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Business: Endocrine/Metabolic Teva's Teva U.K. Ltd. launched a generic version of cholesterol therapy atorvastatin in the U.K. The HMG-CoA reductase…
Published on 5/14/2012
-
Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Montreal, Quebec GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Neurology GlaxoSmithKline launched Potiga ezogabine in the U.S. as an …
Published on 5/14/2012
-
Bio-Reference Laboratories Inc. (NASDAQ:BRLI), Elmwood Park, N.J. Business: Infectious Bio-Reference's GenPath Women's Health Laboratory unit launched its GenCerv HPV assay in the U.S to quantify E6 and E7 mRNA levels, …
Published on 5/7/2012
-
BTG plc (LSE:BGC), London, U.K. Business: Other BTG's BTG International Inc. a subsidiary launched Voraxaze glucarpidase in the U.S. to treat patients with toxic levels of methotrexate due to impaired renal function. …
Published on 5/7/2012